683 Capital Management’s Regenxbio RGNX Stock Holding History

683 Capital Management’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-25,000	Closed	-$746K	–	157
2018 Q1	$746K	Hold	25,000	–	–	0.07%	98
2017 Q4	$831K	Hold	25,000	–	–	0.07%	108
2017 Q3	$824K	Hold	25,000	–	–	0.09%	89
2017 Q2	$494K	Buy	+25,000	New	+$484K	0.07%	86

Other funds holding RGNX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

683 Capital Management's RGNX Position: Q2 2018 in Review

683 Capital Management sold out of Regenxbio (RGNX) in Q2 2018, closing a stake of 25,000 shares — an estimated $746K sold.

683 Capital Management first reported a position in RGNX in Q2 2017 and held it in 4 quarters. The position peaked at $831K in Q4 2017. 177 funds tracked by Wall St. Rank hold RGNX as of Q2 2018.

683 Capital Management reported no remaining Regenxbio position as of Q2 2018 after selling out during the quarter.
683 Capital Management sold 25,000 Regenxbio shares in Q2 2018, an estimated $746K.
683 Capital Management first reported a position in Regenxbio in Q2 2017 and held it in 4 quarters.
683 Capital Management's Regenxbio position peaked at $831K in Q4 2017.
177 funds tracked by Wall St. Rank held Regenxbio as of Q2 2018.

Based on 683 Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.